Search Results 221-230 of 16285 for Alirocumab

  1. Oncology (Medical) - Clinical trials

    1. Create a registry of patients having or at risk for cancer of the liver or bile ducts (also known as hepatocellular carcinoma or cholangiocarcinoma), or ...

  2. Umeclidinium and vilanterol (inhalation route) - Side effects & dosage - Mayo Clinic

    Umeclidinium and vilanterol combination should not be used for acute breathing problems or in patients with asthma. Inhaled umeclidinium is an anticholinergic.

  3. A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML) - Mayo Clinic

    About this study. Phase I Dose Escalation: Primary objective is to determine the MTD and the recommended dose for Phase I Extension.

  4. Efficacy And Safety Of Atacicept In Systemic Lupus Erythematosus - Mayo Clinic

    About this study. This is a multi-center, double-blind, randomized, Phase 2b trial to evaluate the efficacy of atacicept in subjects with systemic lupus ...

  5. A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine - Mayo Clinic

    The goal of this study is to find out how well people with solid tumours tolerate long-term treatment with brigimadlin. Brigimadlin is a so-called MDM2 ...

  6. Nifurtimox (oral route) - Side effects & dosage - Mayo Clinic

    Nifurtimox is used to treat Chagas disease (American Trypanosomiasis) in children. Chagas disease is a potentially life-threatening disease caused by the ...

  7. Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

    The purpose of this study is to assess the safety, tolerability and preliminary efficacy of nal-IRI in combination with 5-FU/LV and oxaliplatin in patients not ...

  8. A Study of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction - Mayo Clinic

    Patients transferred in to an UPSTREAM hospital are eligible for inclusion, but the timing for OAP agent administration and diagnostic catheterization begin ...

  9. A Study of Investigational Immunotherapy to Determine the Safety and Effectiveness of Nivolumab and Daratumumab, with or without Pomalidomide and Dexamethasone, in Patients with Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

    The purpose of this study is to determine the side effects of treatment with Nivolumab by itself or in combination in patients with relapsed/refractory ...

  10. Atidarsagene autotemcel (intravenous route) - Side effects & uses - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...